British Journal of Hospital Medicine,
Journal Year:
2024,
Volume and Issue:
unknown, P. 1 - 12
Published: Sept. 19, 2024
Aims/Background
To
investigate
the
application
value
of
a
machine
learning
model
in
predicting
mild
depression
associated
with
migraine
without
aura
(MwoA).
Methods
178
patients
MwoA
admitted
to
Department
Neurology
First
Affiliated
Hospital
Anhui
University
Traditional
Chinese
Medicine
from
March
2022
2024
were
selected
as
subjects.
According
their
inpatient
medical
records,
38
validation
group
by
random
number
method,
and
remaining
140
included
modelling
group.
diagnosis
results,
further
divided
into
Results
The
results
univariate
analysis
Multivariate
logistic
regression
showed
that
gender,
course
disease,
attack
frequency,
headache
duration,
Migraine
Disability
Assessment
Questionnaire
(MIDAS),
Headache
Impact
Test-6
(HIT-6)
score
independent
influencing
factors
for
(p
<
0.05).
receiver
operating
characteristic
(ROC)
area
under
curve
established
prediction
was
0.982
0.901,
respectively,
sensitivity
0.978
0.857,
specificity
0.892
0.929,
respectively.
Conclusion
Gender,
seizure
MIDAS
score,
HIT-6
are
MwoA.
displays
good
performance
Translational Psychiatry,
Journal Year:
2024,
Volume and Issue:
14(1)
Published: Dec. 27, 2024
The
high
comorbidity
of
major
depressive
disorder
(MDD)
with
other
diseases
has
been
well-documented.
However,
the
pairwise
causal
connections
for
MDD
comorbid
networks
are
poorly
characterized.
We
performed
Phenome-wide
Mendelian
randomization
(MR)
analyses
to
explore
bidirectional
associations
between
(N
=
807,553)
and
877
common
from
FinnGen
datasets
377,277).
inverse
variance
weighting
method
was
primary
technique,
methods
(weighted
median
MR-Egger)
were
used
sensitivity
analyses.
Our
MR
showed
that
genetic
liability
is
causally
associated
risks
324
disease
phenotypes
(average
b:
0.339),
including
46
psychiatric
behavioral
disorders
0.618),
18
neurological
0.348),
44
respiratory
0.345),
40
digestive
0.281),
circulatory
0.237),
37
genitourinary
0.271),
66
musculoskeletal
connective
0.326),
22
endocrine
0.302),
others.
In
a
reverse
analysis,
total
51
components
predisposing
various
risk
0.086),
5
infectious
0.056),
11
0.106),
14
oncological
0.108),
0.114).
Bidirectional
identified
15
diseases.
For
most
analyses,
little
evidence
heterogeneity
pleiotropy
detected.
findings
confirmed
extensive
significant
role
predisposition
in
contributing
human
phenotypes,
which
more
pronounced
than
those
seen
analysis
influences
on
MDD.
Translational Andrology and Urology,
Journal Year:
2025,
Volume and Issue:
14(2), P. 258 - 265
Published: Feb. 1, 2025
Prior
research
has
shown
potential
changes
in
cytokine
and
growth
factor
levels
patients
with
urinary
stones,
but
the
causal
relationship
remains
uncertain.
The
purpose
of
this
study
was
to
investigate
between
tract
stones.
This
used
a
two-sample
Mendelian
randomization
(MR)
41
circulating
cytokines
factors
datasets
alongside
stone
disease
(USD)
data.
It
employed
various
analytical
methods
including
inverse
variance
weighted
(IVW)
analysis,
maximum
likelihood
estimation,
MR-Egger
regression,
median
approach,
simple
method,
mode
establish
relationships.
Sensitivity
analysis
included
regression
intercept
test
Cochrane's
Q
statistic.
Using
IVW
an
increase
stem
cell
β
associated
decreased
risk
[odds
ratio
(OR)
=0.9990;
95%
confidence
interval
(CI):
0.9980-0.9999;
P=0.04].
Conversely,
interleukin-18
elevated
stones
(OR
=1.0012;
CI:
1.0002-1.0022;
P=0.01).
Various
consistently
supported
these
findings.
Our
findings
suggest
unidirectional
interleukin-18,
factors,
USD.
indicates
that
may
actively
contribute
development
or
prevention
USD,
offering
new
avenue
for
clinical
intervention
based
on
modulation.
Research Square (Research Square),
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 28, 2025
Abstract
Major
depressive
disorder
(MDD)
is
a
significant
contributor
to
the
burden
of
mental
disorders
in
Africa,
necessitating
an
understanding
its
prevalence
and
risk
factors
across
diverse
socio-cultural
contexts
address
health
disparities
improve
care.
This
cross-sectional
study
analyzed
7,073
adult
participants
from
hospital
settings
Uganda,
Kenya,
Ethiopia,
South
Africa
within
NeuroGAP-Psychosis
study.
Prevalence
estimates,
calculated
with
95%
confidence
intervals,
revealed
overall
rates
0.9%
for
current
MDD
5.1%
lifetime
MDD,
reporting
highest
(2.1%
current,
8.4%
lifetime).
Multilevel
logistic
regression
identified
associations
between
negative
life
events,
alcohol
use,
Kessler
psychological
distress
scores,
while
was
linked
age,
female
sex,
chronic
pain,
frequent
headaches,
positive
psychosis
screening.
These
findings
underscore
need
targeted
interventions
tailored
reduce
studied
populations.
Frontiers in Psychiatry,
Journal Year:
2025,
Volume and Issue:
16
Published: Jan. 30, 2025
Background
Bipolar
disorder
(BD)
is
a
mental
illness
characterized
by
alternating
episodes
of
elevated
mood
and
depression,
while
major
depressive
(MDD)
debilitating
condition
that
ranks
second
globally
in
terms
disease
burden.
Pharmacotherapy
plays
crucial
role
managing
both
BD
MDD.
We
investigated
the
genetic
differences
populations
individuals
with
MDD
BD,
from
perspective,
we
offered
new
insights
into
potential
drug
targets.
This
will
provide
clues
to
Methods
study
employed
genome-wide
association
studies
(GWAS)
summary-data-based
Mendelian
randomization
(SMR)
methods
investigate
underpinnings
patients
bipolar
predict
target
genes.
Genetic
variants
associated
were
identified
through
large-scale
GWAS
datasets.
For
utilized
comprehensive
meta-analysis
comprising
57
cohorts
Europe,
North
America,
Australia,
including
41,917
cases
371,549
controls
European
ancestry.
dataset
included
type
1
2
diagnosed
based
on
DSM-IV,
ICD-9,
or
ICD-10
criteria
standardized
assessments.
MDD,
used
data
Howard
DM
et
al.,
which
integrated
largest
totaling
246,363
561,190
controls.
The
SMR
approach,
combined
expression
quantitative
trait
loci
(eQTL)
data,
was
then
applied
assess
causal
associations
between
these
gene
expression,
aiming
identify
markers
targets
Furthermore,
two-sample
(TSMR)
analyses
performed
explore
links
protein
(pQTL)
disorders.
Results
analysis
revealed
41
druggable
genes
five
appeared
brain
tissue
blood
eQTL
datasets
significantly
risk.
45
found
be
analysis,
three
simultaneously
NEK4
,
common
candidate
for
also
high
risk
diseases
may
help
differentiate
BD.
Specifically,
showed
strong
(β
brain=0.126,
P
FDR=0.001;
βblood=1.158,
FDR=0.003)
brain=0.0316,
FDR=0.022;
βblood=0.254,
FDR=0.045).
Additionally,
notably
linked
(βbrain=0.123,
FDR=2.97E-05;
βblood=1.018,
FDR=0.002),
but
no
significant
2.Moreover,
TSMR
four
proteins
(BMP1,
F9,
ITIH3,
SIGIRR)
affecting
PSMB4
Conclusion
Our
as
key
(MDD),
suggesting
its
biomarker
differentiating
subtypes.
Using
GWAS,
SMR,
approaches,
multiple
risk,
providing
basis
These
findings
offer
promising
directions
precision
medicine
novel
therapeutic
strategies
health
treatment.
JAMA Neurology,
Journal Year:
2025,
Volume and Issue:
unknown
Published: May 5, 2025
Importance
Migraine
and
major
depressive
disorder
are
frequently
comorbid;
however,
evidence
evaluating
the
efficacy
of
preventive
migraine
therapy
in
patients
with
both
diseases
is
limited.
Objective
To
evaluate
safety
fremanezumab
adults
comorbid
disorder.
Design,
Setting,
Participants
The
UNITE
study
was
a
double-blind,
placebo-controlled,
parallel-group,
randomized
clinical
trial
consisting
4-week
screening
period,
12-week
double-blind
open-label
extension
(OLE),
conducted
between
July
9,
2020,
August
31,
2022.
at
55
centers
across
12
countries.
Eligible
were
episodic
(EM)
or
chronic
(CM),
history
according
to
Diagnostic
Statistical
Manual
Mental
Disorders
(Fifth
Edition)
criteria
for
more
months
before
screening,
active
symptoms
depression
(9-item
Patient
Health
Questionnaire
score
10
more)
screening.
Interventions
Patients
1:1
receive
monthly
(225
mg)
matched
placebo.
All
OLE
received
quarterly
(675
mg).
Main
Outcomes
Measures
primary
end
point
mean
change
from
baseline
days
during
period.
Results
Of
540
screened
study,
353
(mean
[SD]
age,
42.9
[12.3]
years;
310
female
[88%];
EM,
48%;
CM,
52%)
eligible
(n
=
175)
placebo
178).
Mean
(SE)
period
−5.1
(0.50;
95%
CI,
−6.09
−4.13)
−2.9
(0.49;
−3.89
−1.96)
(
P
&lt;.001).
Hamilton
Depression
Rating
Scale–17
Items
week
8
−6.0
(0.55;
−7.10
−4.95)
−4.6
(0.54;
−5.66
−3.55)
(least
squares
[SE]
difference:
−1.4
[0.61];
−2.61
−0.22;
.02).
Adverse
events
consistent
other
trials.
maintained
throughout
OLE.
Conclusions
Relevance
Treatment
compared
resulted
significant
reductions
symptoms.
No
new
concerns
observed.
authors’
knowledge,
this
first
trial,
specifically
designed
assess
disorder,
demonstrate
improvements
single
pharmacological
intervention.
Trial
Registration
ClinicalTrials.gov
Identifier:
NCT04041284
Frontiers in Immunology,
Journal Year:
2024,
Volume and Issue:
14
Published: Jan. 8, 2024
Previous
epidemiological
investigations
and
related
research
efforts
consistently
have
outlined
an
observable
association
between
anxiety
disorders
adhesive
capsulitis
(AC).
However,
the
intricate
nature
of
causal
connection
these
entities
has
yet
to
be
fully
clarified.
Therefore,
this
investigative
study
aims
thoroughly
examine
delineate
interrelationship
AC
using
a
bidirectional,
two-sample
Mendelian
randomization
(MR)
approach.
European journal of medical research,
Journal Year:
2024,
Volume and Issue:
29(1)
Published: Jan. 27, 2024
Allergic
rhinitis
(AR)
and
migraine
are
among
the
most
common
public
health
problems
worldwide.
Observational
studies
on
correlation
between
AR
have
reported
inconsistent
results.
This
study
aimed
to
investigate
causal
relationship
of
with
its
subtypes,
including
aura
(MA)
without
(MO).
Bidirectional
two-sample
Mendelian
randomization
(MR)
analysis
was
performed
publicly
available
summary-level
statistics
large
genome-wide
association
estimate
possible
effects.
The
inverse
variance-weighted
method
selected
for
primary
supplemented
weighted
median,
mode,
MR-Egger
methods.
using
summary
effect
estimates
(CAUSE)
were
further
verify
causality.
Several
sensitivity
tests,
leave-one-out,
Cochran's
Q,
intercept,
MR-PRESSO
assess
robustness
did
not
exhibit
a
significant
elevated
risk
any
(odd
ratio
(OR),
0.816;
95%
confidence
interval
(CI),
0.511-1.302;
P
=
0.394),
MA
(OR,
0.690;
CI
0.298-1.593;
0.384),
or
MO
1.022;
0.490-2.131;
0.954).
Consistently,
reverse
MR
reveal
effects
subtypes
AR.
Almost
all
analyses
supported
clear
risk.
More
research
is
warranted
complex
migraine.
BMC Cancer,
Journal Year:
2023,
Volume and Issue:
23(1)
Published: Sept. 20, 2023
Abstract
Background
The
relationship
between
migraine
and
breast
cancer
risk
has
generated
conflicting
findings.
We
attempted
to
assess
the
association
using
Mendelian
randomization
(MR)
analysis.
Methods
selected
genetic
instruments
associated
with
from
a
recently
published
genome-wide
studies
(GWAS).
Inverse
variant
weighted
(IVW)
analysis
was
adopted
as
main
method,
we
also
performed
weighted-median
method
MR‒Egger,
MR
pleiotropy
residual
sum
outlier
(MR-PRESSO),
Robust
Adjusted
Profile
Score
(MR-RAPS)
methods
supplements.
Results
Our
suggested
that
any
(AM)
factor
for
overall
(IVW:
odds
ratio
(OR)
=
1.072,
95%
confidence
intervals
(CI)
1.035–1.110,
P
8.78
×
10
−
5
,
false
discovery
rate
(FDR)
7.36
4
)
estrogen
receptor-positive
(ER+)
OR
1.066,
CI
1.023–1.111,
0.0024;
FDR
0.0108)
but
not
receptor-negative
(ER-)
cancer.
In
its
subtype
analysis,
women
history
of
without
aura
(MO)
had
an
increased
ER-
1.089,
1.019–1.163,
0.0118,
0.0354),
MO
suggestively
(
>
0.05
IVW
<
0.05).
No
significant
heterogeneity
or
horizontal
found
in
sensitivity
Conclusion
This
study
AM
have
ER
+